---
title: Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women…
description: Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women…
---

<https://info.igenomix.com/publications>

# [Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women…](https://info.igenomix.com/publications/implantation-is-apparently-unaffected-by-the-dopamine-agonist-cabergoline-when-administered-to-prevent-ovarian-hyperstimulation-syndrome-in-women-)

 Written by [Sample HubSpot User](https://info.igenomix.com/publications/author/sample-hubspot-user) | 2017 11PM2007 31

[View full post](https://info.igenomix.com/publications/implantation-is-apparently-unaffected-by-the-dopamine-agonist-cabergoline-when-administered-to-prevent-ovarian-hyperstimulation-syndrome-in-women-)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Sample HubSpot User"
  },
  "dateModified" : "2017-08-31T07:35:40.830Z",
  "datePublished" : "2007-11-01T23:00:00Z",
  "headline" : "Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women…",
  "image" : {
    "@type" : "ImageObject",
    "url" : "https://cdn2.hubspot.net/hubfs/2660253/Assets/Circular-image.png"
  },
  "mainEntityOfPage" : "https://info.igenomix.com/publications/implantation-is-apparently-unaffected-by-the-dopamine-agonist-cabergoline-when-administered-to-prevent-ovarian-hyperstimulation-syndrome-in-women-",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Publications"
  }
}
```